Products Information

News Releases

News releases issued by Kyowa Kirin are intended to inform stakeholders of information related to the company's business in a fair manner. Though it may include information concerning pharmaceutical products (including products under development) , it is not for the purpose of promoting, advertising or medical advice.

2022

December 27, 2022

［Pharmaceuticals domain］
Kyowa Kirin Announces Approval of Topical Ophthalmic Mitomycin C Agent in Japan PDF:277KB
December 26, 2022
- CSV
Notice Regarding Execution of the First Transition-Linked Loan for a Japanese food and beverages company
December 23, 2022

［Pharmaceuticals domain］
- IR
Kyowa Kirin to Decide on Construction of a New Warehouse Building at its Takasaki Plant PDF:318KB
December 23, 2022

［Pharmaceuticals domain］
- CSV
Kyowa Kirin’s Ube Plant to Introduce Large-Scale Solar Power Generation System PDF:336KB
December 23, 2022

［Food & Beverages domain］
- Other
Global Beer Consumption by Country in 2021
December 14, 2022

［Pharmaceuticals domain］
- IR
- Research and Technology
Kyowa Kirin Announces Lancet Publication of Phase 2b Study Results for Rocatinlimab (KHK4083/AMG 451) in Adult Patients with Moderate-to-Severe Atopic Dermatitis PDF:435KB
December 7, 2022

［Pharmaceuticals domain］
- IR
- Products and Services
Kyowa Kirin Announces Launch of “G-Lasta® Subcutaneous Injection 3.6 mg BodyPod” in Japan PDF:208KB
December 7, 2022

［Pharmaceuticals domain］
- IR
Notice Concerning Revisions to Financial Earnings Forecast PDF:133KB
December 7, 2022

［Pharmaceuticals domain］
- IR
MEI Pharma and Kyowa Kirin Announce Discontinuation of Zandelisib Development Outside of Japan Following Recent FDA Meeting PDF:221KB
November 30, 2022

［Food & Beverages domain］
- Products and Services
Price Revisions For Certain Imported Whiskies and Spirits, RTDs, And Kegged Products
November 25, 2022

［Health Science domain］
- Products and Services
- Research and Technology
Completion Of Human Milk Oligosaccharides (HMOs) Production Facility
November 24, 2022
- Human Resources
Kirin Holdings Recognized By The PRIDE Index As An LGBTQ+-friendly Workplace, Receiving Gold Status For The Sixth Year In A Row
November 24, 2022
- Research and Technology
New Cleansing Agent Development Process Utilizing AI And Molecular Simulation Technologies Examined: Collaboration with Kirin Holdings, FANCL, and Keio University
November 18, 2022

［Pharmaceuticals domain］
- IR
- Research and Technology
Kyowa Kirin and MEI Pharma Announce Topline Data from the Phase 2 MIRAGE Study Evaluating Zandelisib in Patients with Indolent B-cell non-Hodgkin’s Lymphoma in Japan PDF:296KB
November 18, 2022

［Food & Beverages domain］
- Products and Services
Château Mercian Mariko Winery Chosen Yet Again By “World’s Best Vineyards 2022”
November 14, 2022

［Pharmaceuticals domain］
- IR
Kyowa Kirin Announces Application for Partial Change of Romiplate® for Aplastic Anemia in Japan PDF:234KB
November 11, 2022

［Health Science domain］
- CSV
- Research and Technology
Kirin Holdings and Kao Begin Joint Research On The Relationship Between Visceral Fat and Immunology
November 11, 2022

［Health Science domain］
- CSV
The KIRIN HEALTH INNOVATION FUND Invests In BackTech, Developer Of Pocket Therapist® , A Labor Productivity Improvement Support Service For Employees
November 9, 2022
- CSV
Kirin Holdings Signs the COP15 Business Statement for Mandatory Assessment and Disclosure
October 31, 2022

［Pharmaceuticals domain］
- IR
- Research and Technology
Kyowa Kirin Announces NDA Submission of Tenapanor Hydrochloride (KHK7791) for Improvement of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis in Japan PDF:285KB
October 21, 2022

［Pharmaceuticals domain］
- Research and Technology
Kyowa Kirin Announces Presentations of the Results of Phase 3 Studies of Tenapanor Hydrochloride (KHK7791) for Hemodialysis Patients with Hyperphosphatemia in Japan at the American Society of Nephrology Meeting PDF:314KB
October 19, 2022

［Health Science domain］
- CSV
- Products and Services
Kirin Expands Lineup Of Functional Food Products for Immune Function With L. lactis strain Plasma To 38, More Than Double
October 18, 2022
- Other
OMRON Invests In Kirin Techno-System, a Comprehensive Manufacturer Of Inspection Machines
October 6, 2022

［Pharmaceuticals domain］
- IR
- Research and Technology
Kyowa Kirin Initiated CVC PDF:207KB
October 3, 2022
- CSV
Kirin Holdings To Participate In The Ministry of the Environment’s 30by30 Alliance For Biodiversity Through The Mariko Vineyard
September 30, 2022

［Health Science domain］
- CSV
iMUSE Wins 2022 Product of the Year Award in the Immune Support Category at the Nutralngredients-Asia Awards
September 29, 2022

［Food & Beverages domain］
- Products and Services
Consulting Business For Start-up Wineries
September 21, 2022
- IR
(Progress of disclosed matters) Withdrawal of Filings for Commercial Arbitration and Liquidation in Regards to the Myanmar Business PDF:227.4KB
September 16, 2022

［Pharmaceuticals domain］
- Products and Services
- Research and Technology
Kyowa Kirin Announces Application for Partial Change of Approved Indication of LUMICEF® for Palmoplantar Pustulosis in Japan PDF:267KB
September 15, 2022
- Human Resources
Kirin Holdings Engages With The Human Capital Management Consortium As A Promoter

Next 1 2 3 4

Next 1 2 3 ... 4

Archives